• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Next-Generation Sequencing-Based Molecular Profiling Using Cell-Free DNA: A Valuable Tool for the Diagnostic and Prognostic Evaluation of Patients With Gastric Cancer.

作者信息

Jang Mi-Ae

机构信息

Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Ann Lab Med. 2024 Mar 1;44(2):119-121. doi: 10.3343/alm.2023.0391. Epub 2023 Oct 26.

DOI:10.3343/alm.2023.0391
PMID:37880993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10628754/
Abstract
摘要

相似文献

1
Next-Generation Sequencing-Based Molecular Profiling Using Cell-Free DNA: A Valuable Tool for the Diagnostic and Prognostic Evaluation of Patients With Gastric Cancer.基于下一代测序的游离DNA分子谱分析：胃癌患者诊断和预后评估的重要工具
Ann Lab Med. 2024 Mar 1;44(2):119-121. doi: 10.3343/alm.2023.0391. Epub 2023 Oct 26.
2
Identification of Potential Genomic Alterations Using Pan-Cancer Cell-Free DNA Next-Generation Sequencing in Patients With Gastric Cancer.利用胃癌患者的泛癌游离 DNA 下一代测序鉴定潜在的基因组改变。
Ann Lab Med. 2024 Mar 1;44(2):164-173. doi: 10.3343/alm.2023.0187. Epub 2023 Oct 30.
3
Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.循环游离核酸和血小板作为液体活检在肺癌患者个性化治疗中的应用
Lung Cancer. 2017 May;107:100-107. doi: 10.1016/j.lungcan.2016.04.026. Epub 2016 May 4.
4
A pilot study of next generation sequencing-liquid biopsy on cell-free DNA as a novel non-invasive diagnostic tool for Klippel-Trenaunay syndrome.下一代测序-液体活检测序技术在游离 DNA 中的应用研究：一种用于 Klippel-Trenaunay 综合征的新型无创诊断工具
Vascular. 2021 Feb;29(1):85-91. doi: 10.1177/1708538120936421. Epub 2020 Jun 26.
5
Non-invasive lung cancer diagnosis and prognosis based on multi-analyte liquid biopsy.基于多分析物液体活检的非侵入性肺癌诊断与预后评估
Mol Cancer. 2021 Jan 29;20(1):23. doi: 10.1186/s12943-021-01323-9.
6
Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients.液体活检中的纳米孔测序：来自肺癌患者游离 DNA 的拷贝数变异分析。
Mol Cancer. 2021 Feb 12;20(1):32. doi: 10.1186/s12943-021-01327-5.
7
Application and optimization of minimally invasive cell-free DNA techniques in oncogenomics.微创游离DNA技术在肿瘤基因组学中的应用与优化
Tumour Biol. 2018 Feb;40(2):1010428318760342. doi: 10.1177/1010428318760342.
8
Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.游离DNA与下一代测序助力肺癌个性化医疗
Oncotarget. 2016 Oct 25;7(43):71013-71035. doi: 10.18632/oncotarget.11717.
9
Targeted next-generation sequencing of circulating free DNA enables non-invasive tumor detection in myxoid liposarcomas.循环游离DNA的靶向新一代测序可实现黏液样脂肪肉瘤的无创肿瘤检测。
Mol Cancer. 2022 Feb 14;21(1):50. doi: 10.1186/s12943-022-01523-x.
10
Identifying molecular drivers of gastric cancer through next-generation sequencing.通过下一代测序技术鉴定胃癌的分子驱动因素。
Cancer Lett. 2013 Nov 1;340(2):241-6. doi: 10.1016/j.canlet.2012.11.029. Epub 2012 Nov 20.

引用本文的文献

1
Evaluation of the diagnostic and prognostic clinical values of circulating tumor DNA and cell-free DNA in pancreatic malignancies: a comprehensive meta-analysis.循环肿瘤DNA和游离DNA在胰腺恶性肿瘤中的诊断及预后临床价值评估：一项全面的荟萃分析
Front Oncol. 2024 Jun 25;14:1382369. doi: 10.3389/fonc.2024.1382369. eCollection 2024.

本文引用的文献

1
Identification of Potential Genomic Alterations Using Pan-Cancer Cell-Free DNA Next-Generation Sequencing in Patients With Gastric Cancer.利用胃癌患者的泛癌游离 DNA 下一代测序鉴定潜在的基因组改变。
Ann Lab Med. 2024 Mar 1;44(2):164-173. doi: 10.3343/alm.2023.0187. Epub 2023 Oct 30.
2
Cost-Effectiveness Analysis of Three Diagnostic Strategies for the Detection of Mutation in Advanced Non-Small Cell Lung Cancer.三种诊断策略检测晚期非小细胞肺癌突变的成本效益分析。
Ann Lab Med. 2023 Nov 1;43(6):605-613. doi: 10.3343/alm.2023.43.6.605. Epub 2023 Jun 30.
3
Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives.循环肿瘤 DNA 于胃腺癌：未来的临床应用与展望。
Int J Mol Sci. 2023 May 29;24(11):9421. doi: 10.3390/ijms24119421.
4
The Role of Cell-Free DNA in Cancer Treatment Decision Making.游离DNA在癌症治疗决策中的作用。
Cancers (Basel). 2022 Dec 12;14(24):6115. doi: 10.3390/cancers14246115.
5
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers.循环肿瘤 DNA 分析预测食管和胃癌患者复发风险。
JCO Precis Oncol. 2022 Dec;6:e2200420. doi: 10.1200/PO.22.00420.
6
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.胃癌：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2022 Oct;33(10):1005-1020. doi: 10.1016/j.annonc.2022.07.004. Epub 2022 Jul 29.
7
Clinical Practice Guidelines for Pre-Analytical Procedures of Plasma Epidermal Growth Factor Receptor Variant Testing.《血浆表皮生长因子受体变异检测分析前程序临床实践指南》。
Ann Lab Med. 2022 Mar 1;42(2):141-149. doi: 10.3343/alm.2022.42.2.141.
8
The Emerging Role of Liquid Biopsy in Gastric Cancer.液体活检在胃癌中的新兴作用
J Clin Med. 2021 May 13;10(10):2108. doi: 10.3390/jcm10102108.
9
Gastric cancer.胃癌。
Lancet. 2020 Aug 29;396(10251):635-648. doi: 10.1016/S0140-6736(20)31288-5.
10
Application of Next Generation Sequencing in Laboratory Medicine.下一代测序在医学实验室中的应用。
Ann Lab Med. 2021 Jan;41(1):25-43. doi: 10.3343/alm.2021.41.1.25. Epub 2020 Aug 25.